Prospective Comparison of Surgery Alone and Chemoradiotherapy With Selective Surgery in Resectable Squamous Cell Carcinoma of the Esophagus

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 2, 2009, Pages 348-356

  Ariga, Hisanori ^a   Nemoto, Kenji ^b   Miyazaki, Shukichi ^a   Yoshioka, Takashi ^b   Ogawa, Yohishiro ^a   Sakayauchi, Toru ^a   Jingu, Keiichi ^a   Miyata, Go ^a   Onodera, Ko ^a   Ichikawa, Hirofumi ^a   Kamei, Takashi ^a   Kato, Shunsuke ^a   Ishioka, Chikashi ^a   Satomi, Susumu ^a   Yamada, Shogo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Esophageal cancer; Metastatic relapse; Salvage resection; Surgery

Indexed keywords

AFTER-TREATMENT; CHEMORADIOTHERAPY; CIS-PLATIN; ESOPHAGEAL CANCER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGECTOMY; FLUOROURACIL; METASTATIC RELAPSE; PRIMARY TREATMENT; PROGRESSIVE DISEASE; SALVAGE RESECTION; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOMES;

CELL MEMBRANES; FLUORESCENT SCREENS; PLATINUM COMPOUNDS; SURGERY;

TELEVISION PICTURE TUBES;

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; CANCER CHEMORADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER THERAPY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DERMATITIS; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HEART DISEASE; HUMAN; INTERMETHOD COMPARISON; LUNG DISEASE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PATIENT COMPLIANCE; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; SALVAGE THERAPY; SKIN TOXICITY; SPINAL CORD DISEASE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 69549086489     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.086     Document Type: Article

References (20)

1. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281 (1999) 1623-1627
2. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 20 (2002) 1167-1174
3. Daly J.M., Karnell L.H., and Menck H.R. National Cancer Data Base report on esophageal carcinoma. Cancer 78 (1996) 1820-1828
4. Stahl M., Stuschke M., Lehmann N., et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23 (2005) 2310-2317
5. Bedenne L., Michel P., Bouche O., et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25 (2007) 1160-1168
6. Ishikura S., Nihei K., Ohtsu A., et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21 (2003) 2697-2702
7. Hironaka S., Ohtsu A., Boku N., et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57 (2003) 425-433
8. Hermanek P., and Sobin L. TNM classification of malignant tumors. Fourth ed (1987), Springer-Verlag, Berlin
9. Ohtsu A., Boku N., Muro K., et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17 (1999) 2915-2921
10. Miyazaki S., and Satomi S. Definitive chemoradiotherapy and salvage esophagectomy for squamous cell carcinoma of the esophagus [In Japanese]. Nippon Geka Gakkai Zasshi 105 (2004) 485-488
11. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
12. Wilson K.S., and Lim J.T. Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: Goal of cure with organ preservation. Radiother Oncol 54 (2000) 129-134
13. Coia L.R., Minsky B.D., Berkey B.A., et al. Outcome of patients receiving radiation for cancer of the esophagus: Results of the 1992-1994 Patterns of Care Study. J Clin Oncol 18 (2000) 455-462
14. Liao Z., Zhang Z., Jin J., et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60 (2004) 1484-1493
15. Swisher S.G., Wynn P., Putnam J.B., et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123 (2002) 175-183
16. Gardner-Thorpe J., Hardwick R.H., and Dwerryhouse S.J. Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg 94 (2007) 1059-1066
17. Gebski V., Burmeister B., Smithers B.M., et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncol 8 (2007) 226-234
18. Jingu K., Nemoto K., Kaneta T., et al. Temporal change in brain natriuretic Peptide after radiotherapy for thoracic esophageal cancer. Int J Radiat Oncol Biol Phys 69 (2007) 1417-1423
19. Blazeby J.M., Farndon J.R., Donovan J., et al. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 88 (2000) 1781-1787
20. Bonnetain F., Bouche O., Michel P., et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): Chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 17 (2006) 827-834